Top of the Street: pharma, SocGen, Antofagasta, Wise, Castellum
BUZZ-Top of the Street: pharma, SocGen, Antofagasta, Wise, Castellum A round-up of notable broker activity this morning from Europe's top-ranked* analysts:
** HSBC cuts both Switzerland's Roche ROPC.S and Germany's Merck MRCG.DE to "hold" from "buy" citing more balanced risk-reward profile for both, with recovery expectations largely priced in
** Kepler Cheuvreux ups Societe Generale SOGN.PA to "buy" from "hold" citing the French bank's potential role in European banking consolidation and a compelling standalone investment case
** J.P. Morgan raises Antofagasta ANTO.L to "overweight" from "neutral" citing "peer leading" organic growth and an improving FCF profile, seeing Chilean miner as well-positioned to benefit from emerging structural deficits in the copper industry
** Kepler Cheuvreux raises Unicaja Banco UNI.MC to "buy" from "hold" on consolidation potential, saying the Spanish bank offers an increasingly compelling value-creation opportunity
** Barclays upgrades Swedish real estate company Castellum CAST.ST to "equal weight" from "underweight" saying that a prospective share buyback offsets a weaker earnings base
INITIATIONS AND REINSTATEMENTS
** J.P. Morgan initiates coverage on U.S.-listed stock of Wise WSE.O with "overweight", expecting the money transfer company to deliver revenue growth above mid-term guidance in H1
** Deutsche Bank resumes coverage of Nemetschek NEKG.DE with "buy" citing the German software firm's Q1 results, acquisition of construction-management software provider HCSS and FX impacts
(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)
(Reporting by Marta Frackowiak and Alessandro Parodi)
((marta.frackowiak@thomsonreuters.com;alessandro.parodi@thomsonreuters.com))